Morin Hydrate Improves Kidney Functions in DEHP-Intoxicated Mice via NF-kB/TNFα/Oxidative Stress/Apoptosis Pathway
- PMID: 40341851
- DOI: 10.1002/jbt.70294
Morin Hydrate Improves Kidney Functions in DEHP-Intoxicated Mice via NF-kB/TNFα/Oxidative Stress/Apoptosis Pathway
Abstract
Di (2-ethylhexyl) phthalate (DEHP) is a plasticiser used in plastic products; and it dissolves easily and leaks into the environment. Due to its lipophilic nature, DEHP accumulates in organisms and can bioaccumulate through food chains. The natural flavonoid, like morin hydrate, possesses various pharmacological properties, including anti-inflammatory, antioxidant, and free radical scavenging. The purpose of this study was to investigate the effect of morin hydrate (MH) on kidney function of DEHP-treated mice. To investigate the underlying processes of the proposed objective, DEHP (500 mg/kg) and DEHP, along with MH at doses of 10 and 100 mg/kg, were administered to Swiss albino mice for 14 days. Our results showed that MH treatment improved kidney function by decreasing creatinine and urea levels in DEHP-intoxicated mice. Furthermore, the MH also alleviates DEHP-induced kidney fibrosis and kidney histoarchitecture. DEHP-mediated oxidative stress and stimulated apoptosis in the kidney were also mitigated by MH treatment. The elevated expression of NF-kB/TNF-α by the DEHP treatment was also down-regulated by the MH treatment. In addition, the abundance of HSP70 increased in the kidneys after DEHP treatment, and MH treatment also decreased the abundance of HSP70 in the kidneys. In conclusion, DEHP treatment caused kidney toxicity in mice, and MH mitigates the kidney functions via modulating NF-kB/TNF-α/oxidative stress/apoptosis pathway. Our findings provide the new findings that MH protects the kidneys from DEHP intoxication, highlighting the potential of MH as a protective treatment for DEHP toxicity and offering hope for future research and treatments.
Keywords: DEHP; NF‐kB; TNF‐α; apoptosis; oxidative stress.
© 2025 Wiley Periodicals LLC.
References
-
- S. S. S. Rowdhwal and J. Chen, “Toxic Effects of Di‐2‐ethylhexyl Phthalate: An Overview,” BioMed Research International 2018 (February 2018): 1750368, https://doi.org/10.1155/2018/1750368.
-
- Y. Wang and H. Qian, “Phthalates and Their Impacts on Human Health,” Healthcare 9, no. 5 (May 2021): 603, https://doi.org/10.3390/healthcare9050603.
-
- N. Liu, Y. Wang, Q. Yang, et al., “Probabilistic Assessment of Risks of Diethylhexyl Phthalate (DEHP) in Surface Waters of China on Reproduction of Fish,” Environmental Pollution 213 (2016): 482–488, https://doi.org/10.1016/j.envpol.2016.03.005.
-
- J. W. Chang, K. W. Liao, C. Y. Huang, et al., “Phthalate Exposure Increased the Risk of Early Renal Impairment in Taiwanese Without Type 2 Diabetes Mellitus,” International Journal of Hygiene and Environmental Health 224 (2020): 113414, https://doi.org/10.1016/j.ijheh.2019.10.009.
-
- L. Trasande, S. Sathyanarayana, and H. Trachtman, “Dietary Phthalates and Low‐Grade Albuminuria in US Children and Adolescents,” Clinical Journal of the American Society of Nephrology 9, no. 1 (2014): 100–109, https://doi.org/10.2215/CJN.04570413.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
